Osseointegration for Amputees

An osseointegrated prosthesis has three parts. Inside the bone sits a titanium implant with a surface that bone grows into, the same principle used in dental implants. Passing through the skin at the end of the residual limb is a short connector, called an abutment, and onto this the external prosthetic limb is attached with a safety coupling designed to release under excessive force so the bone is protected. Because load travels from the prosthesis through the connector into the skeleton, the soft tissue is no longer carrying weight. Users generally gain a wider range of hip or knee movement, can sit without a socket brim pressing into the groin, and report osseoperception, a sense of surface and vibration transmitted through the bone.

Osseointegration is considered mainly for amputees who have tried socket prostheses and cannot use them well. Typical reasons include persistent pain at the socket interface, recurrent skin breakdown, ulcers or infection, excessive sweating, a residual limb that is too short or too scarred to hold a socket, marked volume fluctuation that makes fit unreliable, and severe restriction of hip or knee movement. It is most established for above-knee amputation and is also used below the knee and, less commonly, in the arm. It is not usually offered where the bone is of poor quality, where blood supply to the limb is impaired, where an infection is active, or where the individual cannot commit to the daily care of the skin exit site and to a structured rehabilitation programme.

Planning uses radiographs and computed tomography to measure the bone and select the implant size. The procedure may be done in a single stage or in two. In the two-stage approach, the first operation opens the end of the residual limb, prepares the marrow cavity and inserts the implant, which is then left covered while bone grows onto it for about 6 to 12 weeks. In the second, shorter operation the connector is brought out through a small, carefully shaped opening in the skin, and the soft tissue around it is trimmed so that the skin sits stable and adherent against the connector rather than moving over it. Nerve endings that cause phantom or stump pain may be treated at the same time with a targeted muscle reinnervation or a nerve interface technique. In a single-stage approach both steps are combined. Weight is not applied until the loading programme begins.

Candidacy is assessed by a surgical and rehabilitation team together. It includes imaging of bone quality and length, a vascular assessment, screening for infection and diabetes control, a review of smoking status, and an evaluation of how the person currently walks and what they need to achieve. Bone density is measured where there is reason for concern, since load must eventually pass through the skeleton. Expectations are discussed openly, including the permanent skin opening and the lifelong hygiene routine. Prehabilitation to strengthen the hip and trunk usually starts before surgery. For international patients, imaging, prosthetic history and rehabilitation notes can be reviewed remotely, and the two operative stages and the loading programme are scheduled together before travel.

Loading is the heart of the recovery. Starting a few weeks after the connector is exposed, the user stands on a short training prosthesis with a measured weight, which is increased step by step over several weeks as the bone adapts. The definitive prosthesis is fitted once full body weight is tolerated, and gait training then rebuilds walking pattern, balance and endurance. Most people walk with their definitive limb between 3 and 6 months. Daily care of the skin exit site, washing with soap and water and keeping it dry, begins in hospital and continues for life. Treatment abroad is usually planned as a stay of about 3 to 6 weeks around the operative stages, with the graded loading programme continued at home under a written protocol and reviewed remotely, or as two visits separated by the bone ingrowth period.

The most frequent complication is superficial infection or irritation where the connector passes through the skin, which is usually treated with local care and a short course of antibiotics and rarely threatens the implant. Deeper bone infection is uncommon but serious and can require removal of the implant. Other recognised risks include loosening or failure of the implant, fracture of the bone around it, breakage of the connector or safety coupling after a fall, soft tissue redundancy that needs revision, and persistent phantom pain. Because the implant transmits load directly to the skeleton, high-impact activities such as running and jumping are generally restricted. Published series and long-term follow-up report substantial gains in daily prosthesis use, walking distance, sitting comfort and quality of life for people who could not tolerate a socket, and most implants remain in place long term.